MSN initiates phase III trials of Molnupiravir
Hyderabad, 25 May : MSN Laboratories Pvt. Ltd. (MSN) on Tuesday announced it is initiating phase III clinical trials of Molnupiravir capsules for the treatment of Covid-19 in India.MSN received clinical trial approval from the Drug Controller Gener…